Physician profile
Mark A Parker
NPI 1033103189
$6,704.12
in general payments reported to CMS, 2019-2025
24 companies · $81.02 in 2025
The $81.02 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,256 · 2020: $2,596 · 2021: $1,259 · 2022: $180 · 2023: $247 · 2024: $84.48 · 2025: $81.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,102.60 | 2019-2021 | |
| Baxter Healthcare | $511.20 | 2021 | |
| Medtronic, INC. | $273.13 | 2023-2025 | Progrip, Interstim, Parietene Ds |
| Ethicon US, LLC | $198.35 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $119.89 | 2021-2022 | |
| Davol INC. | $97.28 | 2022 | |
| Axonics, INC. | $77.60 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $31.70 | 2024 | Myrisk |
| Baudax Bio INC. | $29.34 | 2020-2021 | |
| Concordia Pharmaceuticals INC. | $27.95 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $27.51 | 2022-2023 | Seglentis |
| La Jolla Pharmaceutical Company | $26.23 | 2020-2023 | Xerava |
| W. L. Gore & Associates, INC. | $26.00 | 2025 | Gore Enform Intraperitoneal Biomaterial |
| Kerecis Limited | $19.49 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Tela Bio, INC. | $19.12 | 2024 | Ovitex 2s |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $16.87 | 2019 | |
| Solventum Corporation | $15.28 | 2025 | V.A.C. Veraflo, Prevena |
| Medtronic Vascular, INC. | $14.66 | 2019 | |
| Convatec INC. | $13.87 | 2020 | |
| Lsi Solutions INC | $12.35 | 2020 | |
| Boston Scientific Corporation | $11.61 | 2019 | |
| Zyla Life Sciences, INC. | $11.04 | 2020 | |
| Prescient Surgical | $10.98 | 2019 | |
| Thd America, INC. | $10.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.